Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
An interesting article regarding the omicron variant of the coronavirus has recently been published in The Lancet.
New trials published with hepatitis B patients suggests the use of liposome nanoparticles with virus antigens for their treatment.
We analyze the latest studies carried out regarding post-vacial protection against coronavirus and the appearance of new medications.
Two recent studies carried out with antiviral drugs demonstrate their effectiveness against Coronavirus.
We analyze the need for a third dose of reinforcement against coronavirus and studies published in this regard.
Last studies give light on the duration of the vaccine and the need for reinforcement against the COVID-19.
At the European Congress on Liver Diseases, held at the end of June, an interesting work was presented in relation to fatty liver.
Although numerous studies have been published on COVID-19, works regarding the durability of post-vaccination protection are scarce.
23 de August de 2018
21 de April de 2021
20 de November de 2022